U.S. Patent Nos.
7,364,736 (Antibodies to OPGL)
7,888,101 (Host Cells Comprising Alpha 1, 2 Mannosidase and Culture Methods Thereof)
7,928,205 (Methods for Refolding of Recombinant Antibodies)
8,053,236 (Feed Media)
8,217,153 (Methods and Systems for Isolating Target Molecules from Complex Solutions by Column-Chromatography Using Wash Solutions Containing Organic Solvents)
8,460,896 (Host Cells and Culture Methods)
8,680,248 (Host Cells Comprising Alpha 1, 2 Mannosidase and Culture Methods Thereof)
9,228,168 (Feed Media)
9,359,435 (Methods for Modulating Mannose Content of Recombinant Proteins)
10,106,829 (Overexpression of n-glycosylation Pathway Regulators to Modulate Glycosylation of Recombinant Proteins)
10,227,627 (Overexpression of n-glycosylation Pathway Regulators to Modulate Glycosylation of Recombinant Proteins)
10,513,723 (Decreasing Ornithine Production to Decrease High Mannose Glycoform Content of Recombinant Proteins)
10,583,397 (Process Control Systems and Methods for Use with Filters and Filtration Processes)
10,655,156 (Overexpression of N-glycosylation Pathway Regulators to Modulate Glycosylation of Recombinant Proteins)
10,894,972 (Methods for Increasing Mannose Content of Recombinant Proteins)
11,077,404 (Process Control Systems and Methods for Use with Filters and Filtration Processes)
11,098,079 (Charged Depth Filtration of Antigen-Binding Proteins)
11,192,919 (Removal of Leaked Affinity Purification Ligand)
11,254,963 (Increasing Ornithine Accumulation to Increase High Mannose Glycoform Content of Recombinant Proteins)
11,319,568 (Methods for Increasing Mannose Content of Recombinant Proteins)
11,434,514 (Methods for Increasing Mannose Content of Recombinant Proteins)
11,459,595 (Methods for Increasing Mannose Content of Recombinant Proteins)
11,492,372 (Removal of Leaked Affinity Purification Ligand)
11,946,085 (Methods for Increasing Mannose Content of Recombinant Proteins)
11,952,605 (Methods for Increasing Mannose Content of Recombinant Proteins)
12,084,686 (Antibodies with Modulated Glycan Profiles)
Plaintiffs
Amgen Inc.; Amgen Manufacturing Limited
Defendants
Shanghai Henlius Biotech, Inc.; Shanghai Henlius Biologics Co. Ltd.; Organon & Co.; Organon LLC
Status
Case Ongoing
BPCIA
Y